IMPAKT Breast Cancer Conference (English)
In:
ANNALS OF ONCOLOGY
;
23
, 7
;
1929-1929
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:IMPAKT Breast Cancer Conference
-
Published in:ANNALS OF ONCOLOGY ; 23, 7 ; 1929-1929
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2012-01-01
-
Size:1 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 23, Issue 7
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1653
-
Liquid biopsy to test new treatment strategies in breast cancer: are we there yet?Ignatiadis, M. / Piccart, M. et al. | 2012
- 1655
-
X-ACT: An important step on an unfinished journeyMaughan, T. et al. | 2012
- 1659
-
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumorsBlay, J. Y. / Perol, D. / Le Cesne, A. et al. | 2012
- 1665
-
Body mass index and incidence of localized and advanced prostate cancer-a dose-response meta-analysis of prospective studiesDiscacciati, A. / Orsini, N. / Wolk, A. et al. | 2012
- 1672
-
Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trialsPetrelli, F. / Cabiddu, M. / Borgonovo, K. / Barni, S. et al. | 2012
- 1680
-
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinibReichardt, P. / Blay, J. Y. / Gelderblom, H. / Schlemmer, M. / Demetri, G. D. / Bui-Nguyen, B. / McArthur, G. A. / Yazji, S. / Hsu, Y. / Galetic, I. et al. | 2012
- 1687
-
Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapyHendlisz, A. / Golfinopoulos, V. / Garcia, C. / Covas, A. / Emonts, P. / Ameye, L. / Paesmans, M. / Deleporte, A. / Machiels, G. / Toussaint, E. et al. | 2012
- 1693
-
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306Stintzing, S. / Fischer von Weikersthal, L. / Decker, T. / Vehling-Kaiser, U. / Jager, E. / Heintges, T. / Stoll, C. / Giessen, C. / Modest, D. P. / Neumann, J. et al. | 2012
- 1699
-
The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancerAl-Batran, S. E. / Pauligk, C. / Wirtz, R. / Werner, D. / Steinmetz, K. / Homann, N. / Schmalenberg, H. / Hofheinz, R. D. / Hartmann, J. T. / Atmaca, A. et al. | 2012
- 1706
-
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximabScartozzi, M. / Giampieri, R. / Maccaroni, E. / Mandolesi, A. / Giustini, L. / Silva, R. / Zaniboni, A. / Biscotti, T. / Biagetti, S. / Galizia, E. et al. | 2012
- 1713
-
The prognostic and predictive value of serum CA19.9 in pancreatic cancerHumphris, J. L. / Chang, D. K. / Johns, A. L. / Scarlett, C. J. / Pajic, M. / Jones, M. D. / Colvin, E. K. / Nagrial, A. / Chin, V. T. / Chantrill, L. A. et al. | 2012
- 1723
-
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancerSmit, E. F. / Socinski, M. A. / Mullaney, B. P. / Myrand, S. P. / Scagliotti, G. V. / Lorigan, P. / Reck, M. / Ciuleanu, T. / von Pawel, J. / Karaseva, N. A. et al. | 2012
- 1730
-
Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US OncologyJalal, S. I. / Riggs, H. D. / Melnyk, A. / Richards, D. / Agarwala, A. / Neubauer, M. / Ansari, R. / Govindan, R. / Bruetman, D. / Fisher, W. et al. | 2012
- 1738
-
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinomaHofman, P. / Ilie, M. / Hofman, V. / Roux, S. / Valent, A. / Bernheim, A. / Alifano, M. / Leroy-Ladurie, F. / Vaylet, F. / Rouquette, I. et al. | 2012
- 1744
-
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II studyGeorgoulias, V. / Bozionelou, V. / Agelaki, S. / Perraki, M. / Apostolaki, S. / Kallergi, G. / Kalbakis, K. / Xyrafas, A. / Mavroudis, D. et al. | 2012
- 1750
-
Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patientsRomero, A. / Martin, M. / Oliva, B. / de la Torre, J. / Furio, V. / de la Hoya, M. / Garcia-Saenz, J. A. / Moreno, A. / Roman, J. M. / Diaz-Rubio, E. et al. | 2012
- 1756
-
An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancerDanese, M. D. / OMalley, C. / Lindquist, K. / Gleeson, M. / Griffiths, R. I. et al. | 2012
- 1766
-
Validation of a predictive model that identifies patients at high risk of developing febrile neutropaenia following chemotherapy for breast cancerJenkins, P. / Scaife, J. / Freeman, S. et al. | 2012
- 1771
-
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancerHe, X. / Esteva, F. J. / Ensor, J. / Hortobagyi, G. N. / Lee, M. H. / Yeung, S. C. et al. | 2012
- 1780
-
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trialRayson, D. / Suter, T. M. / Jackisch, C. / van der Vegt, S. / Bermejo, B. / van den Bosch, J. / Vivanco, G. L. / van Gent, A. M. / Wildiers, H. / Torres, A. et al. | 2012
- 1788
-
Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell linesCollins, D. M. / ODonovan, N. / McGowan, P. M. / OSullivan, F. / Duffy, M. J. / Crown, J. et al. | 2012
- 1795
-
Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-kB activationBondong, S. / Kiefel, H. / Hielscher, T. / Zeimet, A. G. / Zeillinger, R. / Pils, D. / Schuster, E. / Castillo-Tong, D. C. / Cadron, I. / Vergote, I. et al. | 2012
- 1803
-
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancerSonpavde, G. / Matveev, V. / Burke, J. M. / Caton, J. R. / Fleming, M. T. / Hutson, T. E. / Galsky, M. D. / Berry, W. R. / Karlov, P. / Holmlund, J. T. et al. | 2012
- 1809
-
Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II studyKiefer, T. / Hirt, C. / Spath, C. / Schuler, F. / Al-Ali, H. K. / Wolf, H. H. / Herbst, R. / Maschmeyer, G. / Helke, K. / Kessler, C. et al. | 2012
- 1813
-
Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcomeSchoenfeld, J. D. / Mauch, P. M. / Das, P. / Silver, B. / Marcus, K. J. / Stevenson, M. A. / Ng, A. K. et al. | 2012
- 1818
-
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trialBehringer, K. / Thielen, I. / Mueller, H. / Goergen, H. / Eibl, A. D. / Rosenbrock, J. / Halbsguth, T. / Eichenauer, D. A. / Fuchs, M. / Reiners, K. S. et al. | 2012
- 1825
-
Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: a cost-utility analysisLiberato, N. L. / Rognoni, C. / Rubrichi, S. / Quaglini, S. / Marchetti, M. / Gorlia, T. / Licitra, L. / Vermorken, J. B. et al. | 2012
- 1832
-
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyGranata, R. / Miceli, R. / Orlandi, E. / Perrone, F. / Cortelazzi, B. / Franceschini, M. / Locati, L. D. / Bossi, P. / Bergamini, C. / Mirabile, A. et al. | 2012
- 1838
-
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohortBarba, M. / Sperati, F. / Stranges, S. / Carlomagno, C. / Nasti, G. / Iaffaioli, V. / Caolo, G. / Mottolese, M. / Botti, G. / Terrenato, I. et al. | 2012
- 1845
-
Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patientsAinsworth, N. L. / Marshall, A. / Hatcher, H. / Whitehead, L. / Whitfield, G. A. / Earl, H. M. et al. | 2012
- 1854
-
Survival in cancer of unknown primary site: population-based analysis by site and histologyHemminki, K. / Bevier, M. / Hemminki, A. / Sundquist, J. et al. | 2012
- 1864
-
Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancerWang, S. / Zhang, Q. Y. / Zhou, R. L. et al. | 2012
- 1869
-
Nutrient-based dietary patterns and the risk of head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology consortiumEdefonti, V. / Hashibe, M. / Ambrogi, F. / Parpinel, M. / Bravi, F. / Talamini, R. / Levi, F. / Yu, G. / Morgenstern, H. / Kelsey, K. et al. | 2012
- 1880
-
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)Bosetti, C. / Lucenteforte, E. / Silverman, D. T. / Petersen, G. / Bracci, P. M. / Ji, B. T. / Negri, E. / Li, D. / Risch, H. A. / Olson, S. H. et al. | 2012
- 1889
-
Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centreSchelenz, S. / Giles, D. / Abdallah, S. et al. | 2012
- 1894
-
Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine-a pooled analysis of over 500 000 subjects in the Asia Cohort ConsortiumBoffetta, P. / Hazelton, W. D. / Chen, Y. / Sinha, R. / Inoue, M. / Gao, Y. T. / Koh, W. P. / Shu, X. O. / Grant, E. J. / Tsuji, I. et al. | 2012
- 1899
-
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patientsBerger, M. / Grignani, G. / Giostra, A. / Ferrari, S. / Ferraresi, V. / Tamburini, A. / Cefalo, G. / Carnevale-Schianca, F. / Vassallo, E. / Picci, P. et al. | 2012
- 1906
-
High-quality care for all children with cancerKnops, R. R. / Hulscher, M. E. / Hermens, R. P. / Hilbink-Smolders, M. / Loeffen, J. L. / Kollen, W. J. / Kaspers, G. J. / Caron, H. N. / Kremer, L. C. et al. | 2012
- 1912
-
Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trialDear, R. F. / Barratt, A. L. / Askie, L. M. / Butow, P. N. / McGeechan, K. / Crossing, S. / Currow, D. C. / Tattersall, M. H. et al. | 2012
- 1919
-
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study)Aranda, E. / Manzano, J. L. / Rivera, F. / Galan, M. / Valladares-Ayerbes, M. / Pericay, C. / Safont, M. J. / Mendez, M. J. / Irigoyen, A. / Arrivi, A. et al. | 2012
- 1926
-
Hepatitis B virus infection adds lymphoma burden in KoreaHuh, J. / Suh, C. et al. | 2012
- 1926
-
Reply to the letter to the editor on hepatitis B virus infection adds lymphoma burden in KoreaShin, A. / Shin, H. R. et al. | 2012
- 1928
-
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasmsCrippa, S. / Partelli, S. / Boninsegna, L. / Falconi, M. et al. | 2012
- 1929
-
IMPAKT Breast Cancer Conference| 2012